Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001997 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals
A NA study, sponsored by Chiron Corporation.
- Completed
- Registry status
- NA
- Development phase
NCT00001997 is a NA study that has completed, run by Chiron Corporation.
The verdict
NCT00001997, a NA study, has completed, sponsored by Chiron Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To investigate the safety of polyethylene glycolated interleukin-2 (PEG IL-2) given subcutaneously in conjunction with antiviral treatment and to explore the effects of treatment on surrogate markers of efficacy and incidence of opportunistic infection and other clinical markers of HIV disease.
Interventions
- DRUG Zidovudine
- DRUG Didanosine
- DRUG Interleukin-2, Polyethylene Glycolated
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001997
The ClinicalTrials.gov registry entry for NCT00001997 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Chiron Corporation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Zidovudine is the first listed.
NCT00001997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001997 about?
NCT00001997 is a clinical study titled "Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals". To investigate the safety of polyethylene glycolated interleukin-2 (PEG IL-2) given subcutaneously in conjunction with antiviral treatment and to explore the effects of treatment on surrogate markers of efficacy and incidence of opportunistic infection and other clinical markers of HIV disease.
What is the current status of trial NCT00001997?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00001997?
The interventions under investigation include: Zidovudine (DRUG), Didanosine (DRUG), Interleukin-2, Polyethylene Glycolated (DRUG).
Who is sponsoring clinical trial NCT00001997?
This trial is sponsored by Chiron Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.